Gen-Plus

Do you know what solid oral dosage forms are made of and what their main ingredients are for?   ◽ Solid oral dosage forms, such as tablets and capsules, consist of various components, each with a specific function to ensure proper delivery and efficacy of the active ingredients.   ◽ Achieving perfect formulation involves understanding these ingredients and their roles. This knowledge is crucial for formulation development, analytical measurements and clinical trials. By leveraging our expertise, we help ensure your products are safe, effective, and of the highest quality. Our innovative approaches and comprehensive analyses can save you time and resources, bringing your products to market faster. Embrace the science behind effective pharmaceuticals with our expert support.

📢 Are you a biotech enthusiast seeking cutting-edge solutions for your project? 👉 Join Conscio Group at BayOConnect 2024 in Munich on July 2-3! Meet Lia Martinez-Montero, BD Director of Conscio Pharma, and discover our comprehensive services for biosimilars and biologics. From precise analytics and clinical trials to batch release, Conscio Group offers full-spectrum support for your pharmaceutical needs. Whether you're bringing a new product to market or advancing your research, we're here to support your next breakthrough.

Succesful Day 1 at the #DrugDeliverySummit in Frankfurt!! Top innovative presentations and insightful discussions during the networking session! Thank you for giving us the opportunity to present one of most innovative case studies. Reach out to Bernd Sterner or to Lia Martinez-Montero for additional information!

Succesful Day 1 at the #DrugDeliverySummit in Frankfurt!! Top innovative presentations and insightful discussions during the networking session! Thank you for giving us the opportunity to present one of most innovative case studies. Reach out to Bernd Sterner or to Lia Martinez-Montero for additional information!

📣 Bernd Sterner, Head of R&D at Gen-Plus GmbH & Co. KG, part of the Conscio Group, will be presenting at the European Drug Delivery Summit 2024 in Frankfurt on June 24-25. Bernd's presentation on "2D Printing Technology for Oral Drug Delivery to Premature Infants" will cover: 🔺 Neonatal Care and Precision Medicine: How 2D printing is revolutionizing treatments for premature infants. 🔺 Hydrocortisone Ink Manufacturing: Insights into developing stable and effective drug formulations for orodispersible films. 🔺 Future Directions: Latest results and future potential of hydrocortisone orodispersible films. Lia Martinez-Montero, BD Director of Conscio Pharma, will also be available to discuss Conscio's comprehensive solutions and innovations in the pharmaceutical industry. 📢 Don’t miss this opportunity to explore the latest advancements in neonatal care and drug delivery technology at the summit. Discover how Conscio is leading the way in pharmaceutical innovation.

📢 Jiri Raska, CCO of Conscio Group's Pharma Division, will be at Summit 2024 in Beijing on June 17, 2024. This prestigious event, organized by the Beijing Office of CzechTrade and GCP-Service International, is your gateway to understanding European clinical trials, regulatory pathways, drug development, and market dynamics. The event is fully booked due to high interest, but more opportunities are coming. In the meantime, you can connect with Jiří directly at jiri.raska@consciogroup.com to schedule an online call or arrange a meeting at upcoming global conferences. Conscio Group offers extensive expertise in: 🔹 Formulation Development 🔹 Analytical R&D 🔹 Pharmaceutical Analysis 🔹 Batch Release 🌍 Our centralized project management ensures seamless coordination, regardless of your location—Asia, America, or Europe. Moreover, with EU regulations, successful entry into one EU country can open doors to the entire European Union. We look forward to discussing how we can support your pharmaceutical development needs. #PharmaceuticalDevelopment #ClinicalTrials #RegulatoryPathways #DrugDevelopment #GlobalPharma #ConscioGroup #Summit2024 #EuropeanMarket #LabExcellence #EndtoEndSolutions

📣 Join us on June 12 for an insightful webinar, "In-Vitro Testing with Buccal Mucosa for Oral Dosage Forms," hosted by Teledyne LABS.   👩🔬 Tanja Führmann, MBA, CEO of Gen-Plus GmbH & Co. KG, a Conscio Group company, will share crucial insights into in-vitro permeation testing, covering buccal membrane preparation and permeation outcomes. With over 20 years of experience in the field, Tanja has led significant research and development projects that have advanced pharmaceutical science. In this event, she will share practical knowledge about how to enhance the accuracy and reliability of permeation testing methods.   👨🔬 Over 130 scientists have already registered. Don’t miss this opportunity to advance your expertise. Register at the link below.   For further inquiries about our In Vitro Permeation Testing service or to schedule a personal meeting, please contact Lia Montero at lia.mmontero@consciogroup.com. https://lnkd.in/eWkhs2NU

At Gen-Plus GmbH & Co. KG (member of Conscio Group) we pride ourselves on being an Excellence Center for in-vitro permeation. Whether you need to prove the #Equivalence of a generic product; or quantify the #permeation of the API in an innovative drug, #IVPT is a very strong tool more and more frequently requested by the #Authorities. This June 12, our CEO Tanja Führmann, MBA will have the honor to act as invited speaker at the #permeation webinar organized by Teledyne LABS. Register now and do not miss the opportunity! Contact us for additional information!

🚀 Join us at the BIO International Convention in San Diego! 🚀 We are excited to announce that Conscio Group will be participating in the prestigious BIO International Convention, taking place from June 3-6 in San Diego, California. This conference is one of the most significant events in the biotechnology and pharmaceutical industries, where leaders from around the world come together to share innovations and develop new business opportunities. Karin Cooke, PhD, Director of Business Development for North America at Conscio Pharma division, will be attending the event. She is eager to meet with partners and those interested in exploring our services and partnership opportunities. Karin is particularly keen to discuss our extensive expertise in pharmaceuticals and biologics analysis, as well as our comprehensive clinical and bioanalytical testing services. Combined with our innovative formulation development capabilities, we offer end-to-end solutions for the pharmaceutical industry. 🌟 Don't miss the opportunity to meet with Karin and explore collaboration possibilities! Contact her to schedule a meeting at karin.cooke@consciogroup.com. We look forward to seeing you in San Diego and building the future of biotechnology together! #BIO2024 #ConscioGroup #Biotech #Pharma #Innovation #Networking #SanDiego

The Conscio Group is expanding its range of services in Austria by acquiring Reference Analytics GmbH. 📢 Reference Analytics is a GMP-certified laboratory in Eisenstadt with a focus on drug analysis, whose highly qualified team has built up experience in analytical method development, transfer and validation. By merging with the Conscio Group, Reference Analytics is now ushering in the next phase of growth together with a strong partner in order to offer its customers a broad portfolio of high-quality services for generics, biosimilars and biologics together with other companies in the group. “We are very proud to be able to add Reference Analytics to the Conscio Group. Our goal is to support pharmaceutical companies in the areas of quality assurance and innovation through high-quality scientific services and customer orientation. The expertise of the Reference Analytics team is impressive and the portfolio perfectly complements our range of services both geographically and technically,” explains Stephan Holl, CEO of the Conscio Group. “Over the last few years, together with our owners, we have built Reference Analytics into a strong partner for the Austrian pharmaceutical industry. We are now very pleased to be taking the next step in our development with Conscio and offering our customers an even more comprehensive service,” comments DI Alexander Doppelreiter, CEO Reference Analytics. The Conscio Group, headquartered in Munich, is a European laboratory services provider with a network of 6 international companies in Austria, Germany, the Czech Republic and the Slovak Republic with a total of over 500 employees. The Conscio companies specialize in offering high-quality analysis and consulting services, particularly for the pharmaceutical and food industries. Since 2021, Conscio has been represented in Austria by LVA, the largest private scientific service provider for the Austrian food industry. At the main location in Klosterneuburg, over 130 highly specialized employees are available to provide expert support to a wide range of customer groups. Behind the Conscio Group is BBA Capital Partners, a long-term family holding company based in Munich.